Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by More And No Mi And Nrt

Research Leaders

9 sponsors active, led by National Institute on Drug Abuse (NIDA)

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (1)
Phase 2 (2)
Phase 3 (1)

Trial Status

Recruiting4
Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06033599Phase 3RecruitingPrimary

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

NCT06307340Not ApplicableActive Not RecruitingPrimary

Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations

NCT07466784Recruiting

CEDRN: Opioid Registry

NCT03696017RecruitingPrimary

Opioid/Benzodiazepine Polydrug Abuse

NCT05006079Phase 2Recruiting

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

NCT01327586Phase 2Completed

Abstinence-Linked Money Management Multisite

Showing all 6 trials

Research Network

Common Treatments

  • More And No Mi And Nrt1
  • Alprazolam1
  • More And Mi And Nrt1
  • Support Group And No Mi And Nrt1
  • Individual Drug Counseling1

Active Sponsors

  • National Institute on Drug Abuse (NIDA)3
  • Wayne State University2
  • Canadian Institutes of Health Research (CIHR)1
  • Yale University1
  • Henry Ford Health System1

Top Investigators

Related Conditions

  • Posttraumatic Stress Disorder1
  • Opioid Use Disorder1
  • Cocaine Dependence1
  • Cocaine Abuse1
  • Opioid Abuse1

Activity Timeline